SavedAdd your journal

Journals / Koşuyolu Heart Journal / 2014 / Cilt: 17 - Sayı: 1

End-Stage Hypertrophic Cardiomyopathy with Impressive Biventricular Hypertrophy: Evaluation with Novel Echocardiographic Modalities

Belirgin Biventriküler Hipertrofi Gösteren Son Dönem Hipertrofik Kardiyomiyopati Olgusu: Yeni Ekokardiyografik Yöntemlerle Değerlendirme

Gamze Babür Güler
Mustafa Kürşat Tigen
Cihan Dündar
Tansu Karaahmet
Pages
60–63
Publication Date
2013-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case of end-stage hypertrophic cardiomyopathy with impressive biventricular hypertrophy which was evaluated with novel echocardiographic modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertrophic cardiomyopathy is the most common genetic cardiac disorder.
📊
Key Findings & Data:This disease, which is the leading cause of sudden cardiac death in young patients, is typically characterized by idiopathic hypertrophy of the left and sometimes the right ventricle.
💡
Conclusion & Impact:We present a case of end-stage hypertrophic cardiomyopathy with impressive biventricular hypertrophy which was evaluated with novel echocardiographic modalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hipertrofik kardiyomiyopati · belirgin hipertrofi · görüntüleme

Abstract

Hypertrophic cardiomyopathy is the most common genetic cardiac disorder. This disease, which is the leading cause of sudden cardiac death in young patients, is typically characterized by idiopathic hypertrophy of the left and sometimes the right ventricle. We present a case of end-stage hypertrophic cardiomyopathy with impressive biventricular hypertrophy which was evaluated with novel echocardiographic modalities.

Özet

Hipertrofik kardiyomiyopati en sık rastlanan genetik kökenli kalp hastalığıdır. Gençlerde gözlenen ani kardiyak ölümün en sık sebebi olan bu hastalıkta tipik olarak sol, bazen de sağ ventrikülün idiyopatik hipertrofisi gözlenmektedir. Bu çalışmada, belirgin biventriküler hipertrofi bulguları gösteren son dönem hipertrofik kardiyomiyopatili bir olgu yeni ekokardiyografik modaliteler ile incelenmiştir.

🔖

Cite This Article

Güler, G. B., Tigen, M. K., Dündar, C., Karaahmet, T. (2013). End-Stage Hypertrophic Cardiomyopathy with Impressive Biventricular Hypertrophy: Evaluation with Novel Echocardiographic Modalities. Koşuyolu Heart Journal, Cilt: 17 - Sayı: 1, 60–63. https://ajindex.com/articles/64019

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Cheng T. Hypertrophic cardiomyopathy is a biventricular disease. Int J Cardiol 200816;129:3-4.
  2. Maron MS, Hauser TH, Duborow E, Horst TA, Kissinger KV, Udelson JE et al. Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol 2007;100:1293-8.
  3. Maron BJ, Piccininno M, Casey SA, Bernabò P, Spirito P. Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. Am J Cardiol 20031;91:626-8. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
  4. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1043-8.
  5. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-25.
  6. Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, et al. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 2010;31:2111-23.
  7. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778-85.
  8. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-30. D’Andrea A, Caso P, Severino S, Cuomo S, Capozzi G, Calabrò P, et al. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J 2006;27:1311-8.
  9. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1175-81. Popović ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyper enhancement magnetic resonance imaging. J Am Soc Echocardiogr 2008;21:1299-305.
  10. Sun JP, Stewart WJ, Yang XS, Donnel